Congestive heart failure: what can we offer our patients?
作者信息
Kostuk W J
机构信息
Division of Cardiology, London Health Sciences Centre, ON.
出版信息
CMAJ. 2001 Oct 16;165(8):1053-5.
Abstract
摘要
相似文献
1
Congestive heart failure: what can we offer our patients?充血性心力衰竭：我们能为患者提供什么？
CMAJ. 2001 Oct 16;165(8):1053-5.
2
Heart failure--are we making progress?心力衰竭——我们有进展吗？
Can J Cardiol. 2002 Oct;18(10):1124-5.
3
Epidemiology and clinical aspects of congestive heart failure.
J Renin Angiotensin Aldosterone Syst. 2003 Sep;4(3):131-6. doi: 10.3317/jraas.2003.020.
4
Clinical definition and epidemiology of advanced heart failure.
Am Heart J. 1998 Jun;135(6 Pt 2 Su):S204-15. doi: 10.1016/s0002-8703(98)70251-0.
5
Factors related to time to admission to specialized multidisciplinary clinics in patients with congestive heart failure.与充血性心力衰竭患者入住专业多学科诊所时间相关的因素。
Can J Cardiol. 2009 Oct;25(10):e347-52. doi: 10.1016/s0828-282x(09)70720-2.
6
Management of congestive heart failure in St. Elizabeth Catholic General Hospital Shisong, cardiac centre.圣伊丽莎白天主教综合医院石松心脏中心充血性心力衰竭的管理
Int J Cardiol. 2011 Mar 3;147(2):318-9. doi: 10.1016/j.ijcard.2010.12.067. Epub 2011 Jan 15.
7
The province of Alberta, Canada avoids the hospitalization epidemic for congestive heart failure patients.加拿大艾伯塔省避免了充血性心力衰竭患者的住院流行情况。
Int J Cardiol. 2004 Aug;96(2):203-10. doi: 10.1016/j.ijcard.2003.06.026.
8
Epidemiology of congestive heart failure: Canadian data from 1970 to 1989.充血性心力衰竭的流行病学：1970年至1989年的加拿大数据。
Can J Cardiol. 1992 Jun;8(5):495-8.
9
The incidence and prevalence of congestive heart failure in Rochester, Minnesota.明尼苏达州罗切斯特市充血性心力衰竭的发病率和患病率。
Mayo Clin Proc. 1993 Dec;68(12):1143-50. doi: 10.1016/s0025-6196(12)60063-9.
10
Application of the Seattle heart failure model in patients >80 years of age enrolled in a tertiary care heart failure clinic.西雅图心力衰竭模型在三级心力衰竭诊所中 >80 岁患者中的应用。
Am J Cardiol. 2012 Dec 1;110(11):1663-6. doi: 10.1016/j.amjcard.2012.07.034. Epub 2012 Aug 22.
引用本文的文献
1
Multidisciplinary heart failure clinics: are they effective in Canada?多学科心力衰竭诊所：它们在加拿大有效吗？
CMAJ. 2005 Jul 5;173(1):53-4. doi: 10.1503/cmaj.050705.
本文引用的文献
1
2
Effect of carvedilol on survival in severe chronic heart failure.卡维地洛对严重慢性心力衰竭患者生存率的影响。
N Engl J Med. 2001 May 31;344(22):1651-8. doi: 10.1056/NEJM200105313442201.
3
How many medicines do patients with heart failure need?
Circulation. 2001 Mar 27;103(12):1611-2. doi: 10.1161/01.cir.103.12.1611.
4
Team management of patients with heart failure: A statement for healthcare professionals from The Cardiovascular Nursing Council of the American Heart Association.心力衰竭患者的团队管理：美国心脏协会心血管护理委员会给医疗保健专业人员的一份声明
Circulation. 2000 Nov 7;102(19):2443-56. doi: 10.1161/01.cir.102.19.2443.
5
Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.氯沙坦与卡托普利对有症状心力衰竭患者死亡率影响的比较：随机试验——氯沙坦心力衰竭生存研究（ELITE II）
Lancet. 2000 May 6;355(9215):1582-7. doi: 10.1016/s0140-6736(00)02213-3.
6
Defining diastolic heart failure: a call for standardized diagnostic criteria.舒张性心力衰竭的定义：呼吁标准化诊断标准。
Circulation. 2000 May 2;101(17):2118-21. doi: 10.1161/01.cir.101.17.2118.
7
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.血管紧张素转换酶抑制剂雷米普利对高危患者心血管事件的影响。
N Engl J Med. 2000 Jan 20;342(3):145-53. doi: 10.1056/NEJM200001203420301.
8
Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.血管紧张素转换酶抑制剂赖诺普利低剂量和高剂量对慢性心力衰竭发病率和死亡率的比较影响。ATLAS研究组
Circulation. 1999 Dec 7;100(23):2312-8. doi: 10.1161/01.cir.100.23.2312.
9
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.螺内酯对重度心力衰竭患者发病率和死亡率的影响。随机螺内酯评估研究调查组。
N Engl J Med. 1999 Sep 2;341(10):709-17. doi: 10.1056/NEJM199909023411001.
10
Rationale and design of the Valsartan Heart Failure Trial: a large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure.缬沙坦心力衰竭试验的基本原理与设计：一项大型跨国试验，旨在评估血管紧张素受体阻滞剂缬沙坦对慢性充血性心力衰竭患者发病率和死亡率的影响。
J Card Fail. 1999 Jun;5(2):155-60. doi: 10.1016/s1071-9164(99)90038-6.
Zotero 插件